Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Seagen Inc.
Dana-Farber Cancer Institute
PMV Pharmaceuticals, Inc
Tizona Therapeutics, Inc
Essen Biotech
IDEAYA Biosciences
Novartis
BicycleTx Limited
Maastricht University Medical Center
Merck Sharp & Dohme LLC
Toray Industries, Inc
Medicenna Therapeutics, Inc.
Sotio Biotech Inc.
Carisma Therapeutics Inc
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
ADC Therapeutics S.A.
Sumitomo Pharma America, Inc.
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Ikena Oncology
Atreca, Inc.
Corvus Pharmaceuticals, Inc.
Kineta Inc.
Hoosier Cancer Research Network
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Incyte Corporation
Incyte Corporation
KitovPharma